韩国重启阿斯利康新冠疫苗接种工作
据《韩联社》引述消息指,韩国新冠疫苗预防接种推进团於今日(12日)重启阿斯利康新冠疫苗接种工作,接种对像包括面向全国特殊学校和各级学校工作人员、高危设施从业者以及60周岁以下人群。当局表示,权衡各年龄段接种利弊後,不建议未满30周岁人群接种该疫苗。
因部分欧洲国家屡次接到接种阿斯利康疫苗後生成血栓的报告,南韩早前叫停疫苗接种,随後召开专家咨询会议对相关案例进行研讨,考虑到接种阿斯利康疫苗後产生脑静脉窦血栓和内脏静脉血栓的案例未在境内出现,而且目前需要通过疫苗接种遏制疫情蔓延,因此决定重启接种计划。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.